PFO Flaherty preferred income fund maintains quarterly dividend amid stable portfolio performance and selective risk management SLE Super reports steep quarterly loss revenue tumbles 30 percent as company battles headwinds CEO signals turnaround strategy RNA Atrium Therapeutics revenue surges 708 in Q1 but shares slip as losses persist Minerva Neurosciences NERV Holds Near Support After Slight Decline Key Levels to Watch US First Quarter GDP Growth Revised Down to 16 Annual Rate QVCGA Q3 2025 Earnings Steep Net Loss Reported Shares Unchanged GigaIPOs Reflect a Growing Malaise in Public Markets The Economist Argues